The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hansard Adam since 2021.
This trader's CIK number is 1805556.
At the time of last reporting, Hansard Adam was the Chief Commercial Officer of Applied Therapeutics, Inc.. (stock ticker symbol APLT).
Also see all insider trading activities at Applied Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | APLT | 0 | $0 | 48,871 | $263,414 | 0 | $0 |
2023 | APLT | 0 | $0 | 10,685 | $28,145 | 0 | $0 |
2021 | APLT | 0 | $0 | 2,894 | $53,104 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-03-14 | APLT | Sale | 48,871 | 5.39 | 263,414 |
2023-11-30 | APLT | Sale | 965 | 1.97 | 1,901 |
2023-09-27 | APLT | Sale | 9,720 | 2.70 | 26,244 |
2021-05-26 | APLT | Sale | 2,894 | 18.35 | 53,104 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hansard Adam (Chief Commercial Officer of Applied Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.